Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers 2025-05-01
  2. The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study 2024-10-19
  3. A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings 2024-03-14

Studies

8 studies carry this tag.

Date range

2021 to 2025

Top journals

  • Alzheimer's research & therapy 3
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • Brain : a journal of neurology 1
  • European journal of nuclear medicine and molecular imaging 1
  • Nature communications 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-05-01 Biomarkers

    The CI group had more longitudinal synapse loss and tau burden increases than HCs.

  2. The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study

    ✓ Peer-reviewed alzhub usefulness score 69 out of 100. Alzheimer's research & therapy 2024-10-19 Biomarkers

    In TAP-TAU, we will investigate the added clinical value of tau-PET in a real-world clinical setting, including memory clinic patients with diagnostic uncertainty after routine work-up.

  3. A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Nature communications 2024-03-14 Biomarkers

    Blood-based biomarkers for screening may guide tau positrion emissition tomography (PET) scan referrals to optimize prognostic evaluation in Alzheimer's disease.

  4. Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023-08-28 Cognitive tests and assessment

    Women show stronger associations between tau PET and cognitive outcomes in preclinical AD.

  5. Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Brain : a journal of neurology 2023-04-01 Biomarkers

    The A+P+T- group showed a slower rate of increase in tau-PET compared to the A+P+T+ group, primarily in neocortical regions.

  6. The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's research & therapy 2023-03-17 Biomarkers

    Neither HOMA-IR nor diabetic status was significantly associated with tau PET SUVR.

  7. Detecting Alzheimer's disease biomarkers with a brief tablet-based cognitive battery: sensitivity to Aβ and tau PET

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's research & therapy 2021-02-08 Cognitive tests and assessment

    The BHA measures are significantly associated with both Aβ and regional tau in vivo imaging markers and could be used for the identification of patients with suspected AD pathology in clinical practice.

  8. Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. European journal of nuclear medicine and molecular imaging 2021-01-04 Biomarkers

    The choice of tau biomarker may differ by disease stage and research goals that seek to maximize sensitivity or specificity.

All topic tags with their study counts